Most Read Articles
Pearl Toh, 3 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 6 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Carbohydrate-, sugar-rich diets up risk of coronary heart disease

21 Sep 2020

A diet that stimulates a high glucose response, such as one rich in carbohydrates or sugar, may increase the risk of coronary heart disease (CHD), according to a large pan-European study.

The European Prospective Investigation into Cancer and Nutrition included a total of 338,325 participants who completed a dietary questionnaire. Covariate-adjusted Cox proportional hazard models were used to estimate hazard ratios (HRs) with 95 percent confidence intervals (CIs) for a CHD event, in relation to intake of glycaemic index (GI), glycaemic load (GL), and carbohydrates.

Of the participants, 6,378 had experienced a CHD event over a median of 12.8 years. An association was found between high GL and greater CHD risk (HR, 1.16, 95 percent CI, 1.02–1.31; highest vs lowest quintile: ptrend=0.035; HR per 50 g/day of GL intake, 1.18, 95 percent CI, 1.07–1.29).

This association was prominent in patients with body mass index (BMI) ≥25 kg/m2 (HR, 1.22, 95 percent CI, 1.11–1.35) but not in those with BMI <25 kg/m2 (HR, 1.09, 95 percent CI, 0.98–1.22; pinteraction=0.022). In addition, such association did not differ between men (HR, 1.19, 95 percent CI, 1.08–1.30) and women (HR, 1.22, 95 percent CI, 1.07–1.40; test for interaction was nonsignificant).

GI also correlated with CHD risk in the continuous model (HR per 5 units/day, 1.04, 95 percent CI, 1.00–1.08). Moreover, high available carbohydrate (HR per 50 g/day, 1.11, 95 percent CI, 1.03–1.18) and high sugar intake (HR per 50 g/day, 1.09, 95 percent CI, 1.02–1.17) were associated with increased CHD risk.

“High carbohydrate intake raises blood triglycerides, glucose, and insulin; reduces high-density lipoproteins; and may increase risk of CHD,” the authors noted. “Epidemiological studies indicate that high dietary GI and GL are associated with increased CHD risk.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 3 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 6 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.